These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6540914)

  • 1. [Principles of drug therapy in urogenital tuberculosis].
    Jungbluth H
    Urologe A; 1984 Jul; 23(4):189-93. PubMed ID: 6540914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in the treatment of urogenital tuberculosis].
    Lipsky H; Stadler W
    Wien Klin Wochenschr; 1988 Sep; 100(17):573-6. PubMed ID: 3188530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current status and conservative and operative therapy of urogenital tuberculosis].
    Zwergel T; Zwergel U; Ziegler M
    Z Urol Nephrol; 1985 Oct; 78(10):529-37. PubMed ID: 2416148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antituberculous therapy-induced toxicity.
    Bharat A; Vedkumar M; Subhash HS; Abraham OC; Mathai D
    J Assoc Physicians India; 2003 May; 51():522-4. PubMed ID: 12974441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ambulatory chemotherapy of urogenital tuberculosis and its side effects].
    Böhm G; Heising J
    Fortschr Med; 1983 Apr; 101(13):570-4. PubMed ID: 6303927
    [No Abstract]   [Full Text] [Related]  

  • 7. [Infectiology of the urogenital tract. 7: Therapy of urogenital tuberculosis--side-effects--drugs--interactions--dose adjustment in decreased kidney function].
    Brühl P
    Fortschr Med; 1997 Jun; 115(18):44-6. PubMed ID: 9324487
    [No Abstract]   [Full Text] [Related]  

  • 8. [Various current problems in the treatment of tuberculosis with special reference to the urinary tract].
    Zorić M; Banić B; Dilberović D; Kapidzić N; Tanasijević M
    Med Arh; 1974; 28(4):385-91. PubMed ID: 4475334
    [No Abstract]   [Full Text] [Related]  

  • 9. [Intensive combined therapy of patients with urogenital tuberculosis].
    Soloveĭ BV; Soloveĭ TP
    Probl Tuberk; 1995; (1):30-2. PubMed ID: 7761376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experiences with new tuberculostatics in the treatment of urogenital tuberculosis (capreomycin, ethambutol, rifampicin)].
    May P; König K
    Z Urol Nephrol; 1969; 62(9):657-62. PubMed ID: 5408556
    [No Abstract]   [Full Text] [Related]  

  • 11. [Infectiology of the urogenital tract. 6: Therapy of urogenital tuberculosis].
    Brühl P
    Fortschr Med; 1997 Jun; 115(17):43-5. PubMed ID: 9312542
    [No Abstract]   [Full Text] [Related]  

  • 12. [Disseminated tuberculosis cutis colliquativa caused by hematogenous dissemination of Mycobacterium tuberculosis].
    Behrendt H; Korting HC; Ring J
    Z Hautkr; 1990 Nov; 65(11):1036-8. PubMed ID: 2080654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EAU guidelines for the management of genitourinary tuberculosis.
    Cek M; Lenk S; Naber KG; Bishop MC; Johansen TE; Botto H; Grabe M; Lobel B; Redorta JP; Tenke P;
    Eur Urol; 2005 Sep; 48(3):353-62. PubMed ID: 15982799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of two treatment regimens for drug-resistant tuberculosis in tuberculosis control project areas: a comparative study].
    Li L; Zheng SH; Chu NH; Xie YG; Yang YZ; Li Q; Wang XM; Yan XL; Tan WG; Miao ZP; Duanmu HJ
    Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(48):3387-91. PubMed ID: 19159566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Conservative treatment of urogenital tuberculosis].
    Kurth KH; Sulmoni A
    Ther Umsch; 1972 Apr; 29(4):232-5. PubMed ID: 5063195
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment results of rifampicin (RFP) resistant isoniazid (INH) susceptible tuberculosis, a hospital based study].
    Yoshiyama T; Ogata H; Ito K; Aono A; Wada M
    Kekkaku; 2007 Feb; 82(2):95-101. PubMed ID: 17373318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tuberculosis, does it always come out right?].
    Steensma JT
    Ned Tijdschr Geneeskd; 1986 Jan; 130(4):145-7. PubMed ID: 3513030
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pulmonary tuberculosis with resistance to 4 antitubercular drugs].
    Reichlin S; Frei R; Reusser P
    Schweiz Med Wochenschr; 1998 Feb; 128(7):264-7. PubMed ID: 9540152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of renal and urethral tuberculosis (lecture)].
    Dovlatian AA
    Probl Tuberk; 1993; (5):26-30. PubMed ID: 8295881
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
    Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
    Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.